Meta Health Limited (SGX: 5DX)
Singapore
· Delayed Price · Currency is SGD 0.0090
0.00 (0.00%)
At close: Sep 12, 2024
Meta Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1.48 | 4.61 | 11.39 | 43.03 | 32.23 | 45.46 | Upgrade
|
| Revenue Growth (YoY) | -59.44% | -59.49% | -73.53% | 33.49% | -29.10% | -2.98% | Upgrade
|
| Cost of Revenue | 1.02 | 3.79 | 9.53 | 22.72 | 17.02 | 23.15 | Upgrade
|
| Gross Profit | 0.46 | 0.83 | 1.86 | 20.3 | 15.21 | 22.31 | Upgrade
|
| Selling, General & Admin | 2.07 | 2.75 | 3.99 | 13.1 | 10.65 | 13.46 | Upgrade
|
| Other Operating Expenses | -0.64 | 0.69 | 1.75 | 4.44 | 3.2 | 4.8 | Upgrade
|
| Operating Expenses | 1.64 | 3.63 | 6.63 | 20.33 | 16.71 | 21.4 | Upgrade
|
| Operating Income | -1.18 | -2.81 | -4.78 | -0.03 | -1.5 | 0.91 | Upgrade
|
| Interest Expense | -0.27 | -0.29 | -0.27 | -0.5 | -0.43 | -0.69 | Upgrade
|
| Interest & Investment Income | - | 0 | 0 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.04 | -0.04 | -0.39 | -0.37 | -0.09 | -0.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.17 | -0.01 | -0.54 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.31 | -3.15 | -5.97 | -0.87 | -2.01 | 0.06 | Upgrade
|
| Impairment of Goodwill | -0.1 | -0.1 | - | -7.05 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.48 | -0.08 | 0 | 9.83 | 0.08 | 0.06 | Upgrade
|
| Asset Writedown | - | - | - | -0.69 | - | - | Upgrade
|
| Legal Settlements | - | - | -1.4 | - | - | - | Upgrade
|
| Pretax Income | -1.9 | -3.33 | -7.37 | 1.21 | -1.94 | 0.12 | Upgrade
|
| Income Tax Expense | - | - | - | -0 | 0.02 | -0.09 | Upgrade
|
| Earnings From Continuing Operations | -1.9 | -3.33 | -7.37 | 1.21 | -1.96 | 0.2 | Upgrade
|
| Earnings From Discontinued Operations | -4.66 | -5.01 | -1.34 | - | - | - | Upgrade
|
| Net Income to Company | -6.56 | -8.34 | -8.71 | 1.21 | -1.96 | 0.2 | Upgrade
|
| Minority Interest in Earnings | -0.07 | -0.07 | 0.05 | -0.05 | - | - | Upgrade
|
| Net Income | -6.63 | -8.41 | -8.66 | 1.16 | -1.96 | 0.2 | Upgrade
|
| Net Income to Common | -6.63 | -8.41 | -8.66 | 1.16 | -1.96 | 0.2 | Upgrade
|
| Shares Outstanding (Basic) | 692 | 643 | 555 | 414 | 374 | 374 | Upgrade
|
| Shares Outstanding (Diluted) | 692 | 643 | 555 | 419 | 374 | 374 | Upgrade
|
| Shares Change (YoY) | 23.83% | 15.76% | 32.45% | 12.01% | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | 0.00 | -0.01 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | 0.00 | -0.01 | 0.00 | Upgrade
|
| Free Cash Flow | -2.71 | -2.65 | -2.74 | -0.08 | 0.08 | 4.31 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.01 | Upgrade
|
| Gross Margin | 30.88% | 17.89% | 16.30% | 47.18% | 47.18% | 49.08% | Upgrade
|
| Operating Margin | -79.98% | -60.82% | -41.94% | -0.06% | -4.66% | 2.01% | Upgrade
|
| Profit Margin | -447.36% | -182.25% | -76.02% | 2.70% | -6.08% | 0.44% | Upgrade
|
| Free Cash Flow Margin | -182.91% | -57.46% | -24.07% | -0.19% | 0.26% | 9.48% | Upgrade
|
| EBITDA | -0.91 | -2.15 | -3.56 | 1.31 | -0.03 | 2.82 | Upgrade
|
| EBITDA Margin | -61.18% | -46.50% | -31.25% | 3.03% | -0.08% | 6.20% | Upgrade
|
| D&A For EBITDA | 0.28 | 0.66 | 1.22 | 1.33 | 1.48 | 1.9 | Upgrade
|
| EBIT | -1.18 | -2.81 | -4.78 | -0.03 | -1.5 | 0.91 | Upgrade
|
| EBIT Margin | -79.98% | -60.82% | -41.94% | -0.06% | -4.66% | 2.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.